Literature DB >> 8549647

Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells.

A Winkler1, G Papsdorf, J Odarjuk, W E Siems, J Fickel, M F Melzig.   

Abstract

Although substance P is known to take part in the regulation of the anterior pituitary, no conclusive evidence for the expression of the tachykinin NK1 receptor has been found yet in the pituitary or pituitary derived cells. With the reverse transcription-polymerase chain reaction (RT-PCR) method we could detect the low abundant transcripts of the NK1 receptor in the rat pituitary and in the AtT20 cell line (clone D16v). Furthermore, the functional expression of the NK1 receptor in AtT20 cells was confirmed by activation of the phosphatidylinositol-calcium second messenger system when the cells were treated with substance P. In addition, binding studies also indicated the functional expression of this receptor in AtT20 cells. Thus we provide the first evidence that the NK1 receptor is expressed in AtT20 cells and the rat pituitary.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549647     DOI: 10.1016/0922-4106(95)90188-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.

Authors:  E V Kuzhikandathil; G S Oxford
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies.

Authors:  D Lorenz; B Wiesner; J Zipper; A Winkler; E Krause; M Beyermann; M Lindau; M Bienert
Journal:  J Gen Physiol       Date:  1998-11       Impact factor: 4.086

3.  Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis.

Authors:  Brady K Atwood; Jacqueline Lopez; James Wager-Miller; Ken Mackie; Alex Straiker
Journal:  BMC Genomics       Date:  2011-01-07       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.